Cannabis and Opioid Use Disorder
Shanna Babalonis, PhD · with National Institute on Drug Abuse (NIDA) · NCT05729932
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–55 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Phase 1
- Target enrollment
- 15
- US sites recruiting
- 1
- Study start
- September 10, 2024
- Record last updated
- June 18, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This study plans to enroll participants with opioid use disorder who are not currently seeking treatment to assess the effects of cannabis on opioid withdrawal and other related outcomes.
Being studied: Inhaled vaporized cannabis; Intransal opioid
Conditions: Opioid Use Disorder
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Current opioid use disorder
Exclusion Criteria
- Current medical conditions that require medical management
Recruiting US locations
Center on Drug and Alcohol Research
Lexington, KY 40508
Site contact: Paul Nuzzo, MA · 859-323-0002 · pnuzz2@email.uky.edu
Study contacts (from the official record)
- Paul Nuzzo, MA · 859-323-0002 · pnuzz2@email.uky.edu
Similar studies in Kentucky
All healthy volunteers studies in Kentucky →- RecruitingHealthy volunteersPhase 1
A Clinical Study of Novel Pneumococcal Vaccine V118C in Children (V118C-002)
Merck Sharp & Dohme LLC
- Location
- Louisville, KY + 14 other US sites
- Eligibility basics
- Ages 2 mo–1
- RecruitingHealthy volunteersPhase 1/Phase 2
Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
Xencor, Inc.
- Location
- Louisville, KY + 27 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingHealthy volunteersPhase 1/Phase 2
Study of GS-4321 in Healthy Participants and Participants With Chronic Hepatitis Delta Virus
Gilead Sciences
- Location
- Louisville, KY + 4 other US sites
- Eligibility basics
- Ages 18–69
- RecruitingHealthy volunteersPhase 1/Phase 2
A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)
Novartis Pharmaceuticals
- Location
- Louisville, KY + 18 other US sites
- Eligibility basics
- Ages 18–100